B Saffari

882 total citations
16 papers, 703 citations indexed

About

B Saffari is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, B Saffari has authored 16 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in B Saffari's work include Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). B Saffari is often cited by papers focused on Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). B Saffari collaborates with scholars based in United States and Germany. B Saffari's co-authors include Philip A. Kern, R B Simsolo, John M. Ong, Lovell A. Jones, Michael F. Press, Juling Ong, Adel K. El‐Naggar, Jay George, Janine F. Felix and Steven C. Stain and has published in prestigious journals such as New England Journal of Medicine, Endocrinology and Journal of Lipid Research.

In The Last Decade

B Saffari

16 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Saffari United States 12 192 177 160 146 140 16 703
Dong Won Byun South Korea 15 300 1.6× 128 0.7× 124 0.8× 275 1.9× 91 0.7× 59 816
Giray Bozkaya Türkiye 14 143 0.7× 78 0.4× 81 0.5× 119 0.8× 80 0.6× 70 643
Pekka Leinonen Finland 15 305 1.6× 72 0.4× 105 0.7× 559 3.8× 273 1.9× 27 1.1k
Rana Malek United States 12 358 1.9× 379 2.1× 66 0.4× 238 1.6× 100 0.7× 40 1.1k
Sharon Li Ting Pek Singapore 14 394 2.1× 103 0.6× 184 1.1× 125 0.9× 196 1.4× 32 857
Iwona Żak Poland 16 133 0.7× 48 0.3× 51 0.3× 90 0.6× 144 1.0× 56 593
Noemi Michetti Italy 9 137 0.7× 103 0.6× 56 0.3× 97 0.7× 123 0.9× 11 612
Parvin Amiri Iran 16 190 1.0× 95 0.5× 79 0.5× 123 0.8× 66 0.5× 33 526
Jaap van Doorn Netherlands 18 445 2.3× 74 0.4× 191 1.2× 681 4.7× 114 0.8× 36 1.1k
Chiara Sardella Italy 20 246 1.3× 65 0.4× 103 0.6× 567 3.9× 69 0.5× 51 960

Countries citing papers authored by B Saffari

Since Specialization
Citations

This map shows the geographic impact of B Saffari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Saffari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Saffari more than expected).

Fields of papers citing papers by B Saffari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Saffari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Saffari. The network helps show where B Saffari may publish in the future.

Co-authorship network of co-authors of B Saffari

This figure shows the co-authorship network connecting the top 25 collaborators of B Saffari. A scholar is included among the top collaborators of B Saffari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Saffari. B Saffari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mozdarani, Hossein, et al.. (2013). Chemosensitivity of Hybridoma Cell Lines to Actinomycin D and Bleomycin Sulfate Compared to Non-hybridoma Cell Lines. Electronic journal of biology. 9(1). 1 indexed citations
2.
Chase, Dana M., et al.. (2008). Preoperative diagnosis of ovarian malignancy—preliminary results of the use of three-dimensional vascular ultrasound. Gynecologic Oncology. 111(2). 373–373. 2 indexed citations
3.
Tewari, Devansu, et al.. (2007). Bevacizumab demonstrates activity in advanced refractory fallopian tube carcinoma. International Journal of Gynecological Cancer. 18(2). 369–372. 6 indexed citations
4.
Tewari, Devansu, et al.. (2006). Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma. Gynecologic Oncology. 102(3). 421–424. 15 indexed citations
5.
Chase, Dana M., et al.. (2006). Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. International Journal of Gynecological Cancer. 16(3). 1465–1469. 18 indexed citations
6.
Saffari, B, Leslie Bernstein, Jane Sullivan‐Halley, et al.. (2005). Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. International Journal of Gynecological Cancer. 15(5). 952–963. 27 indexed citations
7.
Saffari, B, Liane Bernstein, Jane Sullivan‐Halley, et al.. (2005). Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. International Journal of Gynecological Cancer. 15(5). 952–963. 4 indexed citations
8.
Cosenza, Carlos Alberto Nunes, B Saffari, Nicolas Jabbour, et al.. (1999). Surgical management of biliary gallstone disease during pregnancy. The American Journal of Surgery. 178(6). 545–548. 70 indexed citations
9.
Lukas, Jason, Susan Groshen, B Saffari, et al.. (1997). WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.. PubMed. 150(1). 167–75. 74 indexed citations
10.
Saffari, B, Lovell A. Jones, Adel K. El‐Naggar, et al.. (1995). Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.. PubMed. 55(23). 5693–8. 109 indexed citations
11.
Ong, Juling, B Saffari, R B Simsolo, & Philip A. Kern. (1992). Epinephrine inhibits lipoprotein lipase gene expression in rat adipocytes through multiple steps in posttranscriptional processing.. Molecular Endocrinology. 6(1). 61–69. 44 indexed citations
12.
Simsolo, R B, et al.. (1992). Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue.. Journal of Lipid Research. 33(1). 89–95. 69 indexed citations
13.
Saffari, B, et al.. (1992). Regulation of adipose tissue lipoprotein lipase gene expression by thyroid hormone in rats.. Journal of Lipid Research. 33(2). 241–249. 52 indexed citations
14.
Ong, Juling, R B Simsolo, B Saffari, & Philip A. Kern. (1992). The regulation of lipoprotein lipase gene expression by dexamethasone in isolated rat adipocytes.. Endocrinology. 130(4). 2310–2316. 57 indexed citations
15.
Kern, Philip A., et al.. (1990). The Effects of Weight Loss on the Activity and Expression of Adipose-Tissue Lipoprotein Lipase in Very Obese Humans. New England Journal of Medicine. 322(15). 1053–1059. 116 indexed citations
16.
Querfeld, Uwe, et al.. (1990). Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages.. Journal of Lipid Research. 31(8). 1379–1386. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026